Evidence map›Paper›PMID 32309450›Full record

ArticleJournal of diabetes research2020

Association of Serum PSP/REG I

Huimin Zhu, Xiangyun Zhu, Hao Lin, Dechen Liu, Yu Dai, Xianghui Su, Ling Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Huimin ZhuDepartment of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao, Nanjing, Jiangsu 210009, China.ORCID https://orcid.org/0000-0002-7942-9154
Xiangyun ZhuDepartment of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao, Nanjing, Jiangsu 210009, China.
Hao LinPancreatic Research Institute, Southeast University, China.ORCID https://orcid.org/0000-0001-7981-7707
Dechen LiuPancreatic Research Institute, Southeast University, China.ORCID https://orcid.org/0000-0002-2776-441X
Yu DaiNanjing Foreign Language School, Nanjing, Jiangsu 210009, China.
Xianghui SuDepartment of Endocrinology, Changji Branch, First Affiliated Hospital of Xinjiang Medical University, Xinjiang 831100, China.ORCID https://orcid.org/0000-0002-2735-5819
Ling LiDepartment of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao, Nanjing, Jiangsu 210009, China.ORCID https://orcid.org/0000-0003-0083-6978
Zhongda Hospital Southeast University · CNNanjing Foreign Language School · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePancreatic stone protein/regenerating protein I (PSP/REG I

methodsThis cross-sectional study was conducted at Zhongda Hospital, affiliated with Southeast University in China. Serum PSP/REG I

resultsSerum PSP/REG I

conclusionsSerum PSP/REG I

Indexed as

AdolescentAdultAgedAged, 80 and overBlood Urea NitrogenCreatinineCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateHumansKidneyKidney Function TestsLithostathineMaleMiddle AgedCreatinineLithostathineUric Acid

Identifiers

PMID32309450
PMCPMC7132584
OpenAlexW3014047670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.